PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CPRX vs. TPL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CPRX and TPL is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

CPRX vs. TPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%120.00%AugustSeptemberOctoberNovemberDecember2025
35.53%
70.92%
CPRX
TPL

Key characteristics

Sharpe Ratio

CPRX:

1.40

TPL:

4.06

Sortino Ratio

CPRX:

2.29

TPL:

4.54

Omega Ratio

CPRX:

1.26

TPL:

1.67

Calmar Ratio

CPRX:

1.55

TPL:

4.05

Martin Ratio

CPRX:

7.91

TPL:

18.18

Ulcer Index

CPRX:

7.31%

TPL:

10.47%

Daily Std Dev

CPRX:

41.22%

TPL:

46.88%

Max Drawdown

CPRX:

-94.25%

TPL:

-73.05%

Current Drawdown

CPRX:

-5.31%

TPL:

-19.40%

Fundamentals

Market Cap

CPRX:

$2.75B

TPL:

$31.59B

EPS

CPRX:

$1.23

TPL:

$19.52

PE Ratio

CPRX:

18.75

TPL:

70.44

PEG Ratio

CPRX:

0.00

TPL:

0.00

Total Revenue (TTM)

CPRX:

$349.91M

TPL:

$520.04M

Gross Profit (TTM)

CPRX:

$293.37M

TPL:

$475.09M

EBITDA (TTM)

CPRX:

$141.71M

TPL:

$410.29M

Returns By Period

In the year-to-date period, CPRX achieves a 8.58% return, which is significantly lower than TPL's 25.95% return. Over the past 10 years, CPRX has underperformed TPL with an annualized return of 22.71%, while TPL has yielded a comparatively higher 45.95% annualized return.


CPRX

YTD

8.58%

1M

2.67%

6M

35.53%

1Y

55.42%

5Y*

40.51%

10Y*

22.71%

TPL

YTD

25.95%

1M

15.73%

6M

70.92%

1Y

191.17%

5Y*

42.44%

10Y*

45.95%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CPRX vs. TPL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPRX
The Risk-Adjusted Performance Rank of CPRX is 8686
Overall Rank
The Sharpe Ratio Rank of CPRX is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8181
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 8787
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 8989
Martin Ratio Rank

TPL
The Risk-Adjusted Performance Rank of TPL is 9898
Overall Rank
The Sharpe Ratio Rank of TPL is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of TPL is 9898
Sortino Ratio Rank
The Omega Ratio Rank of TPL is 9898
Omega Ratio Rank
The Calmar Ratio Rank of TPL is 9797
Calmar Ratio Rank
The Martin Ratio Rank of TPL is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CPRX vs. TPL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CPRX, currently valued at 1.40, compared to the broader market-2.000.002.001.404.06
The chart of Sortino ratio for CPRX, currently valued at 2.29, compared to the broader market-4.00-2.000.002.004.002.294.54
The chart of Omega ratio for CPRX, currently valued at 1.26, compared to the broader market0.501.001.502.001.261.67
The chart of Calmar ratio for CPRX, currently valued at 1.55, compared to the broader market0.002.004.006.001.554.05
The chart of Martin ratio for CPRX, currently valued at 7.91, compared to the broader market-10.000.0010.0020.0030.007.9118.18
CPRX
TPL

The current CPRX Sharpe Ratio is 1.40, which is lower than the TPL Sharpe Ratio of 4.06. The chart below compares the historical Sharpe Ratios of CPRX and TPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
1.40
4.06
CPRX
TPL

Dividends

CPRX vs. TPL - Dividend Comparison

CPRX has not paid dividends to shareholders, while TPL's dividend yield for the trailing twelve months is around 1.08%.


TTM20242023202220212020201920182017201620152014
CPRX
Catalyst Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TPL
Texas Pacific Land Corporation
1.08%1.37%0.83%1.37%0.88%3.58%0.77%0.75%0.30%0.10%0.22%0.23%

Drawdowns

CPRX vs. TPL - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than TPL's maximum drawdown of -73.05%. Use the drawdown chart below to compare losses from any high point for CPRX and TPL. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-5.31%
-19.40%
CPRX
TPL

Volatility

CPRX vs. TPL - Volatility Comparison

Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 19.27% compared to Texas Pacific Land Corporation (TPL) at 13.15%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than TPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
19.27%
13.15%
CPRX
TPL

Financials

CPRX vs. TPL - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Texas Pacific Land Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab